Amoxil (amoxicillin)

SmithKline Beecham

Approval Status
Approved July 1999

Treatment for


Amoxil, previously given three times a day to pediatric patients, is now available for twice daily dosing. Eliminating the middle dose will make it easier for patients to administer the medicine, as they will no longer have to worry about whether that dose will be given during daycare or school hours. Studies show that, among all types of medications, compliance is generally improved by decreasing the required number of daily doses.

Amoxil is highly active in vitro against Step. Pneumoniae and other common bacteria. It is used primarily as a first-line antibiotic for upper and lower respiratory tract infections. Amoxil can be taken with or without food.

Adverse events include diarrhea and nausea. Amoxil is contraindicated in patients with a history of allergic reaction to any of the penicillins.

Amoxil (amoxicillin) Drug Information

The Amoxil (amoxicillin) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top